Animal Vaccine Market
Animal Vaccine Market Size And Forecast
According to Verified Market Research, the Animal Vaccine Market was valued at USD 7.7 Billion in 2018 and is projected to reach USD 12.35 Billion by 2026, growing at a CAGR of 6.05% from 2019 to 2026.
Global Animal Vaccine Market Outlook
An increasing incidence of zoonotic diseases, factory farming method leading to many diseases among animals, and diseases due to climate change are the major factors augmenting the growth of animal vaccines market. Moreover, the introduction of new animal vaccines by the major key players is further boosting the market growth. For instance, in December 2017, Zoetis launched the vaccine named Vanguard CIV H3N2/H3N8 Vaccine. Furthermore, the initiatives taken by several governments such as European government and animal wellness programs led by various animal welfare organizations is further expected to propel the market growth. However, lack of animal health awareness and the possibility of the adverse impact of veterinary vaccines on human or other animal health might restrict the growth of the animal vaccine market.
Global Animal Vaccine Market Competitive Landscape
The Global Animal Vaccine Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Phibro Animal Health, Vetoquinol, Hester, Hipra, and Ceva.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.